CLINICAL TRIALS PROFILE FOR QUILLICHEW ER
✉ Email this page to a colleague
All Clinical Trials for quillichew er
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT03580005 ↗ | A 6-week Study to Evaluate the Safety and Efficacy of Quillichew ERCT in 4-5 Year Old Children With ADHD. | Withdrawn | Pfizer | Phase 4 | 2018-10-31 | A 6-week double-blind study to evaluate the safety and efficacy of Quillichew extended release chewable tablets in 4-5 year old children with attention deficit hyperactivity disorder. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for quillichew er
Condition Name
Clinical Trial Progress for quillichew er
Clinical Trial Phase
Clinical Trial Sponsors for quillichew er
Sponsor Name